May 2020 Vol. 8 No.5

Abstract
Full text
Reprint (PDF) (100 KB)

Search Pubmed for articles by:
 

Original Research Article

Fasting insulin level and Homatest IR as a predictors of Hepatic encephalopathy in critically ill patients

Ahmed Fayed¹, Ahmed Soliman¹, Mohamed Badr², Mohamed Abdelmoniem², Hesham Drwesh^3*, Mohamed Fakher⁴ and Mahmoud Salem Soliman⁵

¹Nephrology Unit, Internal Medicine Department, School of Medicine, Cairo University, Egypt
²Critical Care Medicine and Emergency Department, Faculty of Medicine, Helwan University, Egypt
³ICU Department, Theodor Bilharz Research Institute, Egypt.
⁴Critical Care Medicine, Faculty of Medicine, Cairo University
⁵Anaesthesia Department, Faculty of Medicine, Cairo University

*Corresponding Author’s E-mail: Drwesh703@gmail.com

Received: 02 April 2020 I Accepted: 24 May 2020 I Published: 28 May 2020
Copyright © 2020 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0.

Abstract

Several methods have been used for diagnosing insulin resistance in humans. Glycemic clamp continues to be the gold standard procedure; however, its complexity limits its application in daily medical practice. Several methods using glycemia and insulinemia measurements, both during fasting or after oral or endovenous glucose overload, have been proposed. The purpose of this study was to identify the fasting insulin level and insulin resistance detected by HOMA-IR test in ICU patients as predictors for hepatic encephalopathy. This was a case-control study. The study was done in the medical intensive care unit (ICU) of the Faculty of Medicine Cairo University, 319 ICU patients were included in the study. Control subjects without acute illness were recruited from the local community, stratified by age and gender to approximate the sepsis cohort. In our study we found that hepatic encephalopathy is associated with statistically significant less fasting insulin levels and less insulin resistance than patients without hepatic encephalopathy. This may be explained by that end stage liver disease is associated with hypoglycaemia due to defective hepatogluconeogenesis which causes reduction in calculation of HOMA test. Our present observations indicate that patients with hepatic encephalopathy are associated with statistically significant less fasting insulin levels and less insulin resistance than patients without hepatic encephalopathy.

Keywords: Fasting insulin level, Hepatic encephalopathy, Homatest IR